Hepatic resection but not radiofrequency ablation results in tumor growth and increased growth factor expression

Annals of Surgery

Volumn 245, Issue 5, 2007, Pages 771-776

  Meredith, Kenneth ^a   Haemmerich, Dieter ^a   Qi, Chen ^a   Mahvi, David ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SURGERY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; LIVER RESECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOFREQUENCY ABLATION; TUMOR GROWTH; TUMOR VOLUME;

ADENOCARCINOMA; ANIMALS; CATHETER ABLATION; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEPATECTOMY; HEPATOCYTE GROWTH FACTOR; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; NEOPLASM, RESIDUAL; TUMOR BURDEN;

EID: 34247591951     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000261319.51744.59     Document Type: Article

References (33)

1. Rhim HM, Dodd GDM. Radiofrequency thermal ablation of liver tumors. J Clin Ultrasound. 1999;27:221-229.
2. Kavolius JM, Fong YM, Blumgart LHM. Surgical resection of metastatic liver tumors. Surg Oncol Clin North Am. 1996;5:337-353.
3. Picardo AM, Karpoff HM, Ng BM, et al. Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation. Surgery. 1998;124:57-64.
4. Stolar CJM, Anderson KDM. Growth of mouse hepatoma following liver resection. J Pediatr Surg. 1980;15:513-516.
5. Jong KPM, Sloof MJM, Vries EDM, et al. Effect of partial liver resection on tumour growth. J Hepatol. 2003;25:109-121.
6. Michalopoulos G, DeFrances M. Liver regeneration. Science. 1997;276:60-66.
7. Michalopoulos G, Houck KA, Dolan ML, et al. Control of hepatocyte replication by two serum factors. Cancer Res. 1984;44:4414-4419.
8. Schirmacher P, Geerts A, Pietrangelo A, et al. Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. Hepatology. 1992;15:5-11.
9. Michalopoulos GK. Liver regeneration: molecular mechanisms of growth control [Review]. FASEB J. 1990;4:176-187.
10. Jiang WG, Hallett MB, Puntis MC. Hepatocyte growth factor/scatter factor, liver regeneration and cancer metastasis [Review]. Br J Surg. 1993;80:1368-1373.
11. Jiang WG, Lloyds D, Puntis MC, et al. Regulation of spreading and growth of colon cancer cells by hepatocyte growth factor. Clin Exp Metastasis. 1993;11:235-242.
12. Di Renzo MF, Narsimhan RP, Olivero M, et al. Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene. 1991;6:1997-2003.
13. Sunitha I, Meighen DL, Hartman DP, et al. Hepatocyte growth factor stimulates invasion across reconstituted basement membranes by a new human small intestinal cell line. Clin Exp Metastasis. 1994;12:143-154.
14. Greene AK, Wiener S, Puder M, et al. Endothelial-directed hepatic regeneration after partial hepatectomy. Ann Surg. 2003;237:530-535.
15. Hioki O, Minemura M, Shimizu Y, et al. Expression and localization of basic fibroblast growth factor (bFGF) in the repair process of rat liver injury. J Hepatol. 1996;24:217-224.
16. Chang CK, Hendy MP, Smith JM, et al. Radiofrequency ablation of the porcine liver with complete hepatic vascular occlusion. Ann Surg Oncol. 2002;9:594-598.
17. Wright AS, Mahvi DM, Haemmerich DG, et al. Minimally invasive approaches in management of hepatic tumors. Surg Technol Int. 2003;11:144-153.
18. Jiao LR, Hansen PD, Havlik R, et al. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors [Comment]. Am J Surg. 1999;177:303-306.
19. Goldberg SN, Gazelle GS, Solbiati L, et al. Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode. Acad Radiol. 1996;3:636-644.
20. Arata MA, Nisenbaum HL, Clark TW, et al. Percutaneous radiofrequency ablation of liver tumors with the LeVeen probe: is roll-off predictive of response? J Vasc Interv Radiol. 2001;12:455- 458.
21. Lu DS, Raman SS, Vodopich DJ, et al. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the 'heat sink' effect. AJR Am J Roentgenol. 2002;178:47-51.
22. Chinn SB, Lee FT Jr, Kennedy GD, et al. Effect of vascular occlusion on radiofrequency ablation of the liver: results in a porcine model [Comment]. AJR Am J Roentgenol. 2001;176:789-795.
23. Lorentzen T. A cooled needle electrode for radiofrequency tissue ablation: thermodynamic aspects of improved performance compared with conventional needle design. Acad Radiol. 1996;3:556-563.
24. Wong SL, Edwards MJ, Chao C, et al. Radiofrequency ablation for unresectable hepatic tumors. Am J Surg. 2001;182:552-557.
25. Llovet JM, Vilana R, Bru C, et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma [Comment]. Hepatology. 2001;33:1124-1129.
26. Wood TF, Rose DM, Chung M, et al. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol. 2000;7:593-600.
27. Mahvi DM, Lee FT Jr. Radiofrequency ablation of hepatic malignancies: is heat better than cold? [Comment]. Ann Surg. 1999;230:9-11.
28. Rose DM, Allegra DP, Bostick PJ, et al. Radiofrequency ablation: a novel primary and adjunctive ablative technique for hepatic malignancies. Am Surg. 1999;65:1009-1014.
29. Bowles BJ, Machi J, Limm WM, et al. Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg. 2001;136:864-869.
30. Organ LW. Electrophysiologic principles of radiofrequency lesion making. Appl Neurophysiol. 1976;39:69-76.
31. Zioncheck TF, Richardson L, DeGuzman GG, et al. The pharmacokinetics, tissue localization, and metabolic processing of recombinant human hepatocyte growth factor after intravenous administration in rats. Endocrinology. 1994;134:1879-1887.
32. Fisher B. Experimental studies of factors influencing hepatic metastases. Cancer. 2003;12:929-932.
33. Wen J, Matsumoto K, Taniura N, et al. Hepatic gene expression of NK4, an HGF-antagonist/angiogenesis inhibitor, suppresses liver metastasis and invasive growth of colon cancer in mice. Cancer Gene Ther. 2004;11:419-430.